Evidence map›Paper›PMID 35372213›Full record

ArticleFrontiers in public health2022

Schistosomiasis Among Female Migrants in Non-endemic Countries: Neglected Among the Neglected? A Pilot Study.

Sílvia Roure, Olga Pérez-Quílez, Xavier Vallès, Lluís Valerio, Israel López-Muñoz, Laura Soldevila, Ariadna Torrella, Gema Fernández-Rivas, Anna Chamorro, Bonaventura Clotet

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Sílvia RoureNorth Metropolitan International Health Unit Programa de Salud Internacional del Institut Català de la Salut (PROSICS), Badalona, Spain.
Olga Pérez-QuílezNorth Metropolitan International Health Unit Programa de Salud Internacional del Institut Català de la Salut (PROSICS), Badalona, Spain.
Xavier VallèsNorth Metropolitan International Health Unit Programa de Salud Internacional del Institut Català de la Salut (PROSICS), Badalona, Spain.
Lluís ValerioNorth Metropolitan International Health Unit Programa de Salud Internacional del Institut Català de la Salut (PROSICS), Badalona, Spain.
Israel López-MuñozNorth Metropolitan International Health Unit Programa de Salud Internacional del Institut Català de la Salut (PROSICS), Badalona, Spain.
Laura SoldevilaNorth Metropolitan International Health Unit Programa de Salud Internacional del Institut Català de la Salut (PROSICS), Badalona, Spain.
Ariadna TorrellaNorth Metropolitan International Health Unit Programa de Salud Internacional del Institut Català de la Salut (PROSICS), Badalona, Spain.
Gema Fernández-RivasMicrobiology Department, Germans Trias i Pujol University Hospital, Badalona, Spain.
Anna ChamorroAIDS Research Institute-IrsiCaixa Foundation, Badalona, Spain.
Bonaventura ClotetAIDS Research Institute-IrsiCaixa Foundation, Badalona, Spain.
Institut Català de la Salut · ESHospital Universitari Germans Trias i Pujol · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESRed de Investigación en Sida · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Schistosomiasis among migrant populations in Europe is an underdiagnosed infection, yet delayed treatment may have serious long-term consequences. In this study we aimed to characterize the clinical manifestations of Schistosoma infection among migrant women, and the degree of underdiagnosis. Methods: We carried out a prospective cross-sectional study among a migrant population living in the North Metropolitan Barcelona area and coming from schistosomiasis-endemic countries. We obtained clinical, laboratory and socio-demographic data from electronic clinical records, as well as information about years of residence and previous attendance at health services. Blood sample was obtained and schistosomiasis exposure was assessed using a specific ELISA serological test. Results: Four hundred and five patients from schistosomiasis-endemic regions were screened, of whom 51 (12.6%) were female. Seropositivity prevalence was 54.8%, but considering women alone we found a prevalence of 58.8% (30 out of 51). The median age of the 51 women was 41.0 years [IQR (35-48)] and the median period of residence in the European Union was 13 years [IQR (10-16)]. Conclusion: The high prevalence of signs and symptoms among seropositive women and number of previous visits suggest a high rate of underdiagnosis and/or delayed diagnosis of

Indexed as

Genital Diseases, FemaleSchistosomiasisTransients and MigrantsAdultCross-Sectional StudiesEuropeFemaleHumansMiddle AgedPilot ProjectsProspective Studiesfemale genital schistosomiasisimported schistosomiasismigrants femalesmigrants population in Europeneglectedschistosomiasis in non-endemic countries

Identifiers

PMID35372213
PMCPMC8965459
OpenAlexW4220862458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.